Education
George Washington University School of Medicine
Certifications
Infectious Disease
Residencies
The George Washington University Medical Center
Fellowships
The George Washington University Medical Center
Clinical / Research Interests
HIV

Clinical Trials

This is a phase 3 open label, multi-center, randomized, active-controlled non-inferiority trial that compares the safety and effectiveness of a 6-week regimen of daily rifapentine against the current standard of 12-16 weeks of rifamycin-based treatment for latent TB infection (LTBI).